J Adolesc Health by Marcell, Arik V. et al.
Scope of sexual and reproductive health care receipt among 
young males aged 15-24
Arik V. Marcell, MD, MPH1, Susannah E. Gibbs, MSPH2, Nanlesta A. Pilgrim, PhD, MPH2, 
Kathleen R. Page, MD1, Renata Sanders, MD, MPH, ScM1, Jacky Jennings, PhD, MPH1, 
Penny S. Loosier, PhD, MPH3, and Patricia J. Dittus, PhD3
1From the Johns Hopkins University, School of Medicine 1800 Orleans Street, Baltimore, MD 
21287, USA
2From the Johns Hopkins University, Bloomberg School of Public Health 615 N. Wolfe Street, 
Baltimore, MD 21205, USA
3From the Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E-44, Atlanta, GA 
30333, USA
Abstract
Objective: To describe young men’s sexual and reproductive healthcare (SRHC) receipt by 
sexual behavior and factors associated with greater SRHC receipt.
Methods: 427 male patients aged 15–24 were recruited from 3 primary care and 2 STD clinics in 
one urban city. Immediately after visit, survey assessed receipt of 18 recommended SRHC services 
across four domains: screening history (sex health, STD/HIV test, family planning); laboratories 
(STDs/HIV); condom products (condoms/lubrication); and counseling (STD/HIV risk reduction, 
family planning, condoms); and demographic, sexual behavior and visit characteristics. 
Multivariable Poisson regressions examined factors associated with each SRHC subdomain 
adjusting for participant clustering within clinics.
Results: 90% were non-Hispanic Black, 61% aged 20–24, 90% sexually active, 71% had female 
partners (FP), and 20% male or male and female partners (M/MFP). Among sexually active males, 
one in ten received all services. Half or more were asked about sexual health and STD/HIV tests, 
tested for STDs/HIV, and counseled on STD/HIV risk reduction and correct condom use. Fewer 
were asked about family planning (23%), provided condom products (32%), and counseled about 
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family planning (35%). Overall and for each subdomain, never sexually active males reported 
fewer services than sexually active males. Factors consistently associated with greater SRHC 
receipt across subdomains included: having M/MFP vs. FP, routine vs. non-STD-acute visit, time 
alone with provider without parent, and seen at STD vs. primary care clinic. Males having FP vs. 
M/MFP reported greater family planning counseling.
Conclusions: Findings have implications for improving young men’s SRHC delivery beyond 
narrow scope of STD/HIV care.
Implications and Contribution
Despite new guidance recommending sexual/reproductive healthcare delivery to young men, little 
is known about young men’s sexual/reproductive healthcare receipt. This study demonstrates that 
few young men aged 15–24 receive sexual/reproductive healthcare services beyond the narrow 
scope of STD/HIV care.
Keywords
male adolescents; young adult men; quality of care; sexual and reproductive health care
Introduction
By age 19, the majority of males have initiated sexual intercourse, and young sexually active 
males aged 15–24 experience negative sexual health outcomes, including sexually 
transmitted diseases (STDs), human immunodeficiency virus (HIV), and unintended partner 
pregnancy [1, 2]. National guidance recommends family planning and sexual and 
reproductive healthcare (SRHC) be delivered to young men [3, 4]. Despite these 
recommendations, and Healthy People 2020’s goal to improve reproductive care to young 
men, little is known about young men’s receipt of core SRHC, including assessment about 
sexual health, past STD/HIV testing, and family planning; STD/HIV laboratories; condom 
provision; and related counseling.
Past work examining males’ SRHC receipt focuses on singular service receipt. Studies 
typically assess if patients ever had sex [5] rather than for the components of a complete 
sexual history, as recommended by the Centers for Disease Control and Prevention’s (CDC) 
Five P’s approach (i.e. asking about Partners, Practices, Prevention of Pregnancy, Protection 
from STDs, and Past History of STDs) [6], or assess for STD/HIV testing only rather than in 
context of other services (e.g., testing, condoms, and counseling). Overall, the literature 
indicates a concerning trend – less than one-quarter of young men report receipt of any 
singular service [5, 7–10]. Although studies examining care receipt among young men 
identified with higher sexual risks demonstrate slightly higher rates of singular services [10, 
11], these studies often use non-clinical samples that limit participants’ recall of care and 
visit-specific service receipt, or conflate access to care with service receipt. One recent 
clinic-based study, which highlights clinicians’ lack of attention to young men’s SRHC, 
reports male adolescents were less likely than females to discuss sexuality during routine 
visits, and, when these discussions did occur, they lasted for 36 seconds or less and omitted 
key sexual health topics (e.g., discussions about sexual orientation, healthy relationships) 
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[12, 13]. One of the few clinic-based studies that examines males’ SRHC counseling receipt 
across multiple topics reports that providers only ever discussed, on average, 3 of 11 topics; 
the most discussed topics were counseling on STD risk reduction (55%), correct condom use 
(38%), and relationships (36%) [14]. Other studies examining SRHC receipt across service 
domains mainly assess for HIV testing along with other singular services (e.g., HIV 
counseling [15], other STD testing [11], intimate partner violence assessment [16], vaccine 
receipt [17]) rather than across multiple SRHC domains.
For adolescents who have not yet initiated sex, the American Academy of Pediatrics (AAP) 
Bright Futures’ guidance discusses that any clinical encounter is an opportunity to teach 
adolescents and their families about healthy sexuality, HIV infection and other STDs, and 
modes of infection transmission, and to provide information about contraception, including 
emergency contraception [4]. CDC also recommends HIV testing start at age 13 regardless 
of sexual behavior [18]. One of the few studies to examine SRHC receipt by sexual 
experience used 1999 Youth Risk Behavior Surveillance data and showed that 19% male 
students who had no sexual experience reported a past year preventive care visit that 
included discussions of pregnancy, STDs or HIV prevention with their provider compared to 
33% of sexually experienced male students [9].
Exploring factors associated with SRHC receipt is important to inform improvements in care 
delivery. For example, adolescents who report time alone with their clinician without a 
parent present during well-visits, as compared to those who did not, report substantially 
higher receipt of anticipatory guidance, including about sexual health [19]. Female as 
compared to male providers deliver preventive services at higher rates [20, 21], but female 
providers report greater discomfort when taking sexual histories from opposite-sex patients 
[22, 23]. Visit type may also influence care-delivery; for example, experts in male health do 
not agree that key SRHC should be delivered to young men during acute visits [24]. Finally, 
not all clinical settings may be equipped to deliver the full-range of SRHC.
Addressing current gaps in the literature, this study’s main goal was to describe young 
men’s receipt of SRHC by sexual experience across four core SRHC service domains – 
assessment for sexual health, past STD/HIV tests, and family planning; STD/HIV 
laboratories; condom supply provision; and related counseling – among a clinical-based 
sample of young men aged 15–24. A secondary goal was to examine the demographic, 
sexual behavior and visit characteristics associated with young men’s greater SRHC receipt 
within each domain.
Methods
Procedures
From August 2014 to September 2016, cross-sectional surveys were conducted among non-
probability (convenience) clinical samples of males aged 15–24. Data were collected for 
approximately two weeks each at three primary care (one academic and two community-
based primary care settings) and two public health STD clinics in a Mid-Atlantic city during 
four surveillance data collection rounds as part of a larger study, which trained non-clinical 
youth-serving professionals in community-based settings to engage young men they work 
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with on SRHC and monitored young men’s knowledge about this intervention. Round 1 
(4/4/14-7/9/14) was conducted prior to intervention initiation and Rounds 2 
(10/27/14-12/12/14); 3 (8/3/15-9/16/15); and 4 (7/1/16-9/30/16) after initiation. Inclusion 
criteria included identifying as a male aged 15–24 and ability to speak, read, and understand 
English or Spanish. Immediately after the visit, participants completed an audio computer-
assisted self-interview that took about 10–15 minutes to complete. Adult participants gave 
consent to participate in research and minor participants gave consent if visits were SRHC-
related; minors’ assent and parent consent was given if visits were non-SRHC-related. Study 
protocols and procedures were approved by the human subjects review boards of the 
affiliated institutions. All participants received a $5 gift certificate for their time. Study 
procedures necessitated clinicians to refer participants or male patients to approach the study 
recruitment table on their own volition. Of 786 males referred to/approached the study team, 
479 (61.0%) were determined to meet the study’s inclusion criteria. Among eligible 
participants, 427 enrolled (89.1% participation rate) and 52 refused (10.9%) (e.g., due to 
time constraints).
Measures
SRHC receipt.
Participants were assessed about receipt of 18 services representing four core SRHC service 
domains – screening history for sexual health, past STD/HIV tests, and family planning; 
STD/HIV-related laboratories; condom provision; and related counseling. Measures were 
developed based on core clinical preventive service recommendations for family planning 
and STDs/HIV [3, 6, 18, 25] and prior work in this area [14, 24]. Based on the number of 
items received at the visit overall and for each subdomain, an additive score was created, 
with higher scores representing greater number of services received.
For screening history, 10 questions were asked, consisting of three separate subdomains: 
screening about sex health (5 items), past STD/HIV tests (2 items), and family planning (3 
items): “Did the doctor you saw today ask you about: have you ever had sex with women, 
men or both; if you are straight, gay, or bisexual; type of sexual behavior you have had 
(vaginal, anal and/or oral sex); number of sex partners; if you used a condom at last sex; 
your plans for having children; if your partner uses a hormonal birth control method; if you 
have ever gotten someone pregnant; last time tested for HIV; and last time tested for STDs 
other than for HIV?”.
For laboratories, 2 questions were asked: “Did doctor: screen you for HIV by a blood test, 
finger prick or mouth swab; and ask you to give a urine sample to screen you for STDs?”
For condom product provision, 2 questions were asked: “Did doctor give you: condoms; and 
any lubrication to use with condoms?”
For counseling, 4 questions were asked, consisting of three separate subdomains: counseling 
about STDs/HIV (1 item), condoms (1 item), and family planning (2 items): “Did doctor 
talk to or counsel you today about: reducing your STD/HIV risk; how to use a condom 
correctly; preventing pregnancy; and emergency contraception?”
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Three other items recommended by men’s health experts were also assessed [31]: “Did 
doctor: ask you today about if you: are having any problems when you have sex (problems 
like coming too quickly, pain, coming too slowly, keeping an erection when having sex); 
have ever had a partner hurt you physically; and talk to/counsel you today about practicing 
how to use a condom correctly with an actual condom and model penis?”
Participant characteristics
Demographics.
Demographic factors assessed included gender (male, female or transgender), age in years 
(15–19 or 20–24); and race/ethnicity (non-Hispanic Black, non-Hispanic White or 
Hispanic).
Sexual behavior.
Participants were asked whether they were ever sexually experienced (no/yes for any type of 
sex including vaginal, oral, or anal sex with specific definitions for each type of sex 
provided); and about the gender of their sex partner(s) (sex with women only, men only, men 
and women, or never sexually active).
Visit.
Visit characteristics assessed included established clinic patient (no/yes); visit reason 
(physical examination (e.g., annual well-care visit), STD screen, STD concern, or other 
(e.g., non-STD and non-health maintenance related issue such as cold or blood pressure 
recheck)); gender of provider seen (male/female); time alone with provider without parent 
present (no/yes); and clinic type (primary care or STD clinic).
Data analysis
Frequencies or means and standard deviations (SD) were first generated for respondents’ 
background characteristics (Table 1) and for each SRHC item, including subdomain and 
composite score by sexual experience (Table 2). Means or frequencies of SRHC were 
compared by sexual experience using ANOVA or Chi-square, respectively. Next, separate 
Poisson regression models examined bivariate (not shown) associations between 
participants’ demographic, sexual behavior and visit characteristics and each SRHC 
subdomain, with each model adjusted for clustering of participants within clinics. A P value 
of <.10 determined the common set of variables to include in the final models. The final set 
of covariates was then assessed for multicollinearity for each SRHC subdomain, and none 
was found. A Poisson model was applied in the multivariable analyses to calculate the 
relative risk (RR), because odds ratios overestimate RR when main outcomes are common 
(>10%) [26]. Separate regression models were conducted where all covariates were entered 
simultaneously into the regression model to produce adjusted incidence rate ratios [26] in 
order to examine the association between participants’ demographic, sexual behavior and 
visit characteristics and each SRHC subdomain and also adjusting for clustering of 
participants within clinics (Table 3). Thus, adjusted RR represent the association of each 
covariate with the dependent variable after accounting for the influence of all of the other 
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variables. Because data were collected over a 2-year period, an indicator variable 
representing the four data collection time points was created to examine its role as a 
potential confounder in each multivariable model. Because no differences were found 
between the multivariable models with and without this indicator variable, data from the 
multivariable analyses for each outcome are summarized without this indicator variable. For 
these analyses, a level of p<0.05 was used for determining statistical significance. All 
analyses were conducted using Stata14.
Results
Of 427 male participants, 2 self-identified as transgender. The majority of patients were aged 
20–24 (61%), non-Hispanic black (90%), sexually experienced (90%), and sexually active 
with women only (71%) (Table 1). About one-third (31%) were new patients and 41% were 
at the clinic for a physical examination, and 46% for an STD screen/concern. The majority 
saw female providers (73%) and had time alone with the provider without a parent present 
(86%). About half each of respondents were seen in STD (46%) and primary care (54%) 
clinics.
SRHC receipt (Table 2)
Screening history.
Sexually active males were asked, on average (standard deviation [SD]), 3.7 (SD=1.8) of 
five sexual health items (12% were asked no items, 51% all items); 1.6 (SD=0.8) of two past 
STD/HIV testing items (18% none, 76% all); and 1.2 (SD=1.2) of three family planning 
items (40% none, 23% all). Never sexually active males reported a lower mean number of 
screening item receipt for each subdomain than sexually active males (sexual health: 1.9 
(SD=1.9); past STD/HIV testing: 0.4 (SD=0.7); and family planning: 0.3 (SD=0.6); all p’s 
<.001).
Laboratories.
Sexually active males were tested, on average, for 1.3 (SD=0.9) of two STD/HIV tests (27% 
reported no tests, 52% both tests). Never sexually active males reported a lower mean 
number of STD/HIV tests than sexually active males (0.5 (SD=0.7); p<.001).
Condom product provision.
Sexually active males were provided, on average, 0.9 (SD=0.9) of two condom products 
(45% provided no products, 32% both products). Never sexually active males reported a 
lower mean number of condom product receipt than sexually active males (0.2 (SD=0.6); 
p<.001).
Counseling.
Sexually active males were counseled on reducing STD/HIV risk (72%), on using condoms 
correctly (50%) and, on average, about 0.9 (SD=0.9) of two family planning topics (45% 
counseled on no topics, 34% both topics). A lower proportion of never sexually active males 
were counseled on STD/HIV risk reduction and condoms than sexually active males (38% 
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and 21%, respectively; all p’s <.001). Never sexually active males reported a lower mean 
number of family planning counseling than sexually active males (0.5 (SD=0.7); p≤.01).
Composite recommended SRHC.
Sexually active males received, on average, 10.7 (SD=5.4) of 18 services (7% received no 
services, 9% all services). Never sexually active males reported a lower mean number of 
SRHC receipt than sexually active males (4.4 (SD=4.6); p<.001).
Additional SRHC items.
Sexually active and never sexually active males reported being asked about history for 
problems when having sex (43% and 10%); about partner ever hurting them physically (37% 
and 12%); and practice using a condom correctly with an actual condom and model penis 
(38% and 5%), respectively.
Factors associated with each SRHC subdomain
Adjusted models showed the most consistent factors that were associated with receipt of a 
greater number of SRHC items across SRHC subdomains included participants’ sexual 
behavior status, sex partner gender, visit reason, having time alone with a provider, and 
clinic type (Table 3).
Sexually active males with female partners only (FP) and males with male or male and 
female partners (M/MFP) were more likely than never sexually active males to report receipt 
of a greater number of screening history items about sexual health (adjusted relative risk 
[aRR]=1.48, 95% CI=1.10–2.00; aRR=1.86, CI=1.37–2.52), past STD/HIV tests (aRR=2.80, 
CI=1.72–4.53; aRR=3.26, CI=2.01–5.30), and family planning (aRR=4.08, CI=2.14–7.78; 
aRR=3.15, CI=1.60–6.20); STD/HIV laboratories (aRR=2.00, CI=1.30–3.10; aRR=2.02, 
CI=1.28 −3.17); condom products (aRR=3.11, CI=1.49–6.48; aRR=3.85, CI=1.81–8.16); 
and condom counseling (aRR=2.10, CI=1.17–3.76; aRR=2.25, CI=1.22–4.15). Compared to 
never sexually active males, males with M/MFPs were more likely to be counseled on 
STD/HIV risk reduction (aRR=1.64, CI=1.11–2.43) and males with FPs only were more 
likely to report receipt of a greater number of family planning counseling items (aRR=1.75, 
CI=1.10–2.79). Males with FPs only were less likely than males with M/MFPs to report 
receipt of a greater number of screening history items about sex health (aRR=0.80, CI=0.72–
0.88) and past STD/HIV tests (aRR=0.86, CI=0.77–0.95); and counseling on STD/HIV risk 
reduction (aRR=0.86, CI=0.75–0.99), and more likely to report receipt of a greater number 
of family planning counseling items (aRR=1.43, CI=1.07–1.92).
Compared to males seen for a routine physical, males seen for acute non-STD-related issues 
were less likely to report receipt of each SRHC subdomain except for condom products, and 
males seen for STD concern/screening were more likely to report being counseled on 
STD/HIV risk reduction. Males who had time alone with the provider without a parent 
present were more likely than those who did not to report receipt of each SRHC subdomain 
except for screening history about family planning and condom product provision. Males 
seen at STD clinics were more likely than those seen in primary care to report receipt of a 
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greater number of STD/HIV-related services (e.g., screening history about sex health, past 
STD/HIV tests, STD/HIV laboratories, and counseling on STD/HIV risk reduction).
Discussion
This study describes that few young male patients received SRHC care across all core 
recommended services or within an SRHC subdomain. Higher proportions of sexually active 
males received STD/HIV laboratories and counseling than family planning services and 
never sexually active males received far fewer services overall. Male patients’ visit 
characteristics differentiated SRHC receipt across all domains. Study findings highlight the 
need to improve providers’ delivery of SRHC services to young men beyond just STD/HIV 
care.
This is one of the first studies to demonstrate that the majority of sexually active young male 
patients did not receive core services across recommended SRHC services. Although reports 
of service receipt in this study, especially related to STD/HIV care, was higher than that 
observed in another clinic-based study [14] and may be due, in part, to use of ACASI for 
data collection, only one in ten sexually active young men in this study reported receiving all 
services. Among SRHC sub-domains, higher levels of service receipt was mainly observed 
for STD/HIV-related services; only half of participants being assessed on all sexual health 
items, less than one-quarter on all family planning items, and less than one-third were 
counseled about family planning. It is possible that male patients received some or all 
services at a prior visit(s), because providers may be distributing services across multiple 
visits rather than all at once. Future work may need to examine SRHC delivery to young 
men over time to fully understand if lower service provision rates are due to prior service 
receipt or providers’ lack of care delivery.
Young male patients who had sex with men (YMSM) more commonly reported STD/HIV-
focused care receipt than males with female partners only. It is possible that clinicians are 
tailoring the care they provide to YMSMs based on past sexual history assessment or that 
YMSMs more proactively request needed care than heterosexual males [27]. Future work 
should examine whether clinicians are individualizing the care they provide to young men. 
This is especially relevant for YMSM who are concerned that providers will judge them as 
being high-risk based solely on their partner’s gender, identity, and orientation [28].
Receipt of family planning services was more commonly reported by male patients with 
female partners only. These findings are consistent with a recent past clinic-based study that 
indicated 38% of young men reported ever discussing with a provider how to use a condom 
correctly, 23% discussed female birth control methods, and 21% emergency contraception 
[14]. Although YMSM in this study were less likely to report family planning counseling, 
other research shows that almost half of males aged 15–24 with only male sexual partners 
also report future plans to have children [29]. Providers should thus not miss opportunities to 
discuss family planning needs with all male patients, including the implications of 
unprotected sex related to STD/HIV risk and potentially the role of assisted reproductive 
technologies.
Marcell et al. Page 8
J Adolesc Health. Author manuscript; available in PMC 2019 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
This is one of a few studies to assess SRHC receipt by males’ sexual experience [9, 13]. For 
key recommended services [4, 18], close to half reported being assessed on each of two of 
five sexual health items and far fewer received any other service including being tested for 
HIV and practice using condoms correctly. Low rates of service receipt in this study are 
consistent with past work [9, 13] and indicate the need to better understand providers’ 
barriers to delivering care to this population and to more concretely define what SRHC this 
population should receive, especially adolescents on the brink of sexual onset [4, 30].
Certain visit factors that differentiated young men’s SRHC receipt in this study may 
represent leverage points that can be used to improve SRHC delivery. Consistent with past 
work, provider private time without a parent was associated with greater SRHC receipt 
across all domains, except for family planning assessment and condom product provision 
[19]. Acute non-STD-related visits were associated with lower SRHC receipt, especially 
quick-to-collect STD/HIV tests. Although these findings are consistent with past work of 
men’s health experts who did not agree whether SRHC should be delivered to young men 
during acute visits [24], any visit, including acute visits, is recommended to be an 
opportunity to deliver key SRHC [3]. This is especially relevant for young men who may 
make fewer than one doctor visit per year [31].
Services assessed in this study focused on core family planning and STD/HIV care 
recommended for young men, but not all recommendations by the recent Providing Quality 
Family Planning Services (QFP) guidance that is intended to serve as the standard of 
preventive care for all providers who deliver SRHC [3, 32]. QFP makes comprehensive 
SRHC recommendations that reproductive-aged men receive family planning (i.e., 
contraception, pregnancy testing and counseling, achieving pregnancy, basic infertility, 
preconception health, and STD services); related preventive (e.g., genital exam to assess 
progress of healthy sexual development); and other preventive services (e.g., lipid 
screening); and that quality family planning delivery needs to be monitored for women and 
men [3, 32]. Findings in this study may thus be foundational toward developing quality care 
measures for young men’s SRHC delivery, since current measures focus solely on services 
delivered to women [33–36]. Future work will need to examine the full implementation of 
QFP recommended services for young men and other quality dimensions including that care 
is safe, patient-centered, timely, and accessible [37]. However, guidelines are necessary but 
not sufficient to observe changes in providers’ behavior [38]. Strategies to improve 
providers’ SRHC delivery to young men may require multi-level intervention approaches 
across settings in which young men are seen [39].
This study has several limitations. It is cross-sectional in design, thus identified findings 
should not be interpreted as causal. Care-receipt is based on self-report and may not 
correspond to actual care delivered. However, past work shows adolescents’ self-reported 
care receipt is valid to determine preventive healthcare receipt especially when recently 
assessed (e.g., past 2–4 weeks) and recall in this study occurred immediately after the visit 
[40]. This study only assessed urine-based STD screening. Future work may want to assess 
screening all sites of STD exposure. Findings may not be generalizable to all males seen in 
clinical settings given non-probability nature of this study as well as generalizable to other 
settings secondary to this majority African American sample from clinics in one city. Future 
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work may want to examine a more diverse sample of patients from similar and/or other 
clinical settings. Finally, the never sexually experienced male sample was small; future work 
will be needed to learn more about SRHC receipt among this sub-population in clinical 
settings. Offsetting these limitations is the study’s description of core SRHC receipt among 
young men aged 15–24.
This study found few young male patients received core SRHC, and care receipt varied 
mainly by patients’ sexual behavior status and visit characteristics. Study findings highlight 
the need to improve providers’ delivery of SRHC services to young men beyond just 
STD/HIV care.
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Acronyms.
CI Confidence Interval
FP female partner
HEDIS Healthcare Effectiveness Data and Information Set
HIV Human immunodeficiency virus
M/MFP male or male and female partner
PIMS Performance Indicator Monitoring System
RQIP Regional Quality Indicators Project
RR Relative risk
QFP Providing Quality Family Planning Services
STD Sexually transmitted diseases
SRHC Sexual and reproductive healthcare
YMSM Young men who have sex with men
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Table 1.
Participants’ demographic, sexual behavior and visit characteristics
N %
Demographic characteristics
Age
 15–19 166 38.9
 20–24 261 61.1
Race/ethnicity
 Non-Hispanic Black 386 90.4
 Non-Hispanic White 30 7.0
 Hispanic 11 2.6
Sexual behavior characteristics
Ever sexual experience
 No 42 9.8
 Yes 385 90.2
Gender of sexual partner
 Women only 302 70.7
 Men only 55 12.9
 Men and women 28 6.6
 Never had sex 42 9.8
Visit characteristics
Established clinic patient
 No (new patient) 134 31.4
 Yes 293 68.6
Visit reason
 Routine physical examination 176 41.2
 STD screen 124 29.0
 STD concern 71 16.6
 Other (e.g., cold) 56 13.1
Provider gender
 Female 310 72.6
 Male 117 27.4
Time alone with provider without
parent present 367 85.9
Clinic type
 Primary care 231 54.1
 STD clinic 196 45.9
STD=sexually transmitted disease
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